Matches in SemOpenAlex for { <https://semopenalex.org/work/W2317070623> ?p ?o ?g. }
- W2317070623 abstract "Ovarian Cancer represents the most fatal type of gynaecological malignancies. The tumor microenvironment consists the region where a number of processes contributing to the pathogenesis of this deadly disease occur. Except the cell proliferation process itself, processes such as angiogenesis can be held accountable for the progress of disease. More specifically, angiogenesis represents a hallmark phenomenon in cancer and a number of studies have shown that it is responsible for the spread of tumor and metastasis in most types of cancer including ovarian cancer. The process leads to new blood vessel formation and stabilization of the tumor vasculature. In recent years angiogenesis has been given considerable attention in order to identify novel targets for developing effective antitumor therapies. Among other families of molecules, growth factors have been identified to play important roles in driving the process of angiogenesis and thus the formation of new blood vessels that play the key role in supplying cancer with appropriate nutrients, hence allowing its spread and metastasis. Such molecules include the vascular endothelial growth factor (VEGF), the platelet derived growth factor (PDGF), the fibroblast growth factor (FGF) and the angiopoietin (Ang)/Tie 2 receptor complex. These proteins are key players in molecular pathways located within the tumor cell and they have been recently under heavy research being in the spotlight of the development of anti angiogenic molecules that may act as stand-alone therapeutics (monotherapy) or in combination with current treatment regimes such as standard chemotherapy. Such molecules include Bevacizumab, Sorafenib, Imatinib mesylate, Sunitinib, Trebananib, Aflibercept, Intedanib, Pazopanib, and Cediranib. There is also a special reference to the possible angio-agenic effect that paclitaxel may confer either in monotherapy or in combination with other agents. The roles of these molecules that have been developed in order to combat angiogenesis are described in this paper." @default.
- W2317070623 created "2016-06-24" @default.
- W2317070623 creator A5012405296 @default.
- W2317070623 creator A5017011213 @default.
- W2317070623 creator A5077194270 @default.
- W2317070623 creator A5078443447 @default.
- W2317070623 date "2014-01-01" @default.
- W2317070623 modified "2023-09-23" @default.
- W2317070623 title "Angio-Inhibitors in Ovarian Cancer" @default.
- W2317070623 cites W110866433 @default.
- W2317070623 cites W1490550714 @default.
- W2317070623 cites W1495198008 @default.
- W2317070623 cites W1504357831 @default.
- W2317070623 cites W1542216227 @default.
- W2317070623 cites W1606254941 @default.
- W2317070623 cites W1658618454 @default.
- W2317070623 cites W1843899331 @default.
- W2317070623 cites W1913665771 @default.
- W2317070623 cites W1961928411 @default.
- W2317070623 cites W1965727465 @default.
- W2317070623 cites W1967830128 @default.
- W2317070623 cites W1970575648 @default.
- W2317070623 cites W1973127894 @default.
- W2317070623 cites W1974218755 @default.
- W2317070623 cites W1975141727 @default.
- W2317070623 cites W1975416889 @default.
- W2317070623 cites W1976448012 @default.
- W2317070623 cites W1978139448 @default.
- W2317070623 cites W1982246723 @default.
- W2317070623 cites W1984143493 @default.
- W2317070623 cites W1985804036 @default.
- W2317070623 cites W1985850927 @default.
- W2317070623 cites W1994855668 @default.
- W2317070623 cites W1996737831 @default.
- W2317070623 cites W1997761243 @default.
- W2317070623 cites W1998846962 @default.
- W2317070623 cites W2000269194 @default.
- W2317070623 cites W2001114848 @default.
- W2317070623 cites W2002215005 @default.
- W2317070623 cites W2003598961 @default.
- W2317070623 cites W2004494623 @default.
- W2317070623 cites W2004825554 @default.
- W2317070623 cites W2007194438 @default.
- W2317070623 cites W2008530096 @default.
- W2317070623 cites W2008771039 @default.
- W2317070623 cites W2012053348 @default.
- W2317070623 cites W2012516785 @default.
- W2317070623 cites W2013288089 @default.
- W2317070623 cites W2013892055 @default.
- W2317070623 cites W2020004435 @default.
- W2317070623 cites W2021645028 @default.
- W2317070623 cites W2022538237 @default.
- W2317070623 cites W2023075445 @default.
- W2317070623 cites W2024741626 @default.
- W2317070623 cites W2034301104 @default.
- W2317070623 cites W2034669369 @default.
- W2317070623 cites W2037761545 @default.
- W2317070623 cites W2041634324 @default.
- W2317070623 cites W2041766813 @default.
- W2317070623 cites W2042177108 @default.
- W2317070623 cites W2042588021 @default.
- W2317070623 cites W2043701048 @default.
- W2317070623 cites W2048797704 @default.
- W2317070623 cites W2052711856 @default.
- W2317070623 cites W2053221827 @default.
- W2317070623 cites W2053358495 @default.
- W2317070623 cites W2054151200 @default.
- W2317070623 cites W2054812499 @default.
- W2317070623 cites W2056739417 @default.
- W2317070623 cites W2057087136 @default.
- W2317070623 cites W2057711788 @default.
- W2317070623 cites W2061931704 @default.
- W2317070623 cites W2064363496 @default.
- W2317070623 cites W2066370100 @default.
- W2317070623 cites W2066508006 @default.
- W2317070623 cites W2070369494 @default.
- W2317070623 cites W2073883983 @default.
- W2317070623 cites W2075711878 @default.
- W2317070623 cites W2076424556 @default.
- W2317070623 cites W2076733823 @default.
- W2317070623 cites W2081169791 @default.
- W2317070623 cites W2082592896 @default.
- W2317070623 cites W2084274206 @default.
- W2317070623 cites W2086619383 @default.
- W2317070623 cites W2087073539 @default.
- W2317070623 cites W2089477889 @default.
- W2317070623 cites W2089756110 @default.
- W2317070623 cites W2091065076 @default.
- W2317070623 cites W2091198832 @default.
- W2317070623 cites W2091849683 @default.
- W2317070623 cites W2092847543 @default.
- W2317070623 cites W2093767005 @default.
- W2317070623 cites W2095882207 @default.
- W2317070623 cites W2097373408 @default.
- W2317070623 cites W2105651363 @default.
- W2317070623 cites W2106439593 @default.
- W2317070623 cites W2106661991 @default.
- W2317070623 cites W2107492221 @default.
- W2317070623 cites W2109400578 @default.
- W2317070623 cites W2112940666 @default.